134
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Wheat Type (Class) Influences Development and Regression of Colon Cancer Risk Markers in Rats

&
Pages 1285-1294 | Received 10 Jul 2015, Accepted 20 Jul 2015, Published online: 16 Oct 2015

REFERENCES

  • Haas P, Machado MJ, Anton AA, Silva AS, and De Francisco A: Effectiveness of whole grain consumption in the prevention of colorectal cancer: Meta-analysis of cohort studies. Int J Food Sci Nutr 60(Suppl. 6), 1–13, 2009.
  • Aune D, Chan DSM, Lau R, Vieria R, Greenwood DC, et al.: Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343, d6617, 2011.
  • Kyro C, Skeie G, Loft S, Landberg R, Christensen J, et al.: Intake of whole grains from different cereal and food sources and incidence of colorectal cancer in the Scandinavian HELGA cohort. Cancer Causes Control 24, 1363–1374, 2013.
  • Buescher MI and Gallaher DD: Wheat color (class), not refining, influences colon cancer risk in rats. Nutr Cancer 66, 849–856, 2014.
  • Slattery ML, Boucher KM, Caan BJ, Potter JD, and Ma K-N: Eating patterns and risk of colon cancer. Am J Epidemiol 148, 4–16, 1998.
  • Pretlow TP, O'Riordan MA, Somich GA, Amini SB, and Pretlow TG: Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13, 1509–1512, 1992.
  • Jenab M, Chen J, and Thompson LU: Sialomucin production in aberrant crypt foci relates to degree of dysplasia and rate of cell proliferation. Cancer Lett 165, 19–25, 2001.
  • Uchida K, Kado S, Ando M, Nagata Y, Takagi A, et al.: A mucinous histochemical study on malignancy of aberrant crypt foci (ACF) in rat colon. J Vet Med Sci 63, 145–149, 2001.
  • Caderni G, Giannini A, Lancioni L, Luceri C, Biggeri A, et al.: Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. Br J Cancer 71, 763–769, 1995.
  • Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, et al.: Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 63, 2388–2392, 2003.
  • Paulsen JE, Loberg EM, Olstorn HB, Knutsen H, Steffensen IL, et al.: Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat. Cancer Res 65, 121–129, 2005.
  • Ochiai M, Ushigome M, Fujiwara K, Ubagai T, Kawamori T, et al.: Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Am J Pathol 163, 1607–1614, 2003.
  • Mori H, Yamada Y, Kuno T, and Hirose Y: Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis. Mutat Res 566, 191–208, 2004.
  • Papailiou J, Bramis KJ, Gazouli M, and Theodoropoulos G: Stem cells in colon cancer. A new era in cancer theory begins. Int J Colorectal Dis 26, 1–11, 2011.
  • Boman BM, Walters R, Fields JZ, Kovatich AJ, Zhang T, et al.: Colonic crypt changes during adenoma development in familial adenomatous polyposis: immunohistochemical evidence for expansion of the crypt base cell population. Am J Pathol 165, 1489–1498, 2004.
  • Molofsky AV, Pardal R, and Morrison SJ: Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 16, 700–707, 2004.
  • Humphries A and Wright NA: Colonic crypt organization and tumorigenesis. Nat Rev Cancer 8, 415–424, 2008.
  • Cook HA, Williams D, and Thomas GA: Crypt-restricted metallothionein immunopositivity in murine colon: validation of a model for studies of somatic stem cell mutation. J Pathol 191, 306–312, 2000.
  • Donnelly ET, Bardwell H, Thomas GA, Williams ED, Hoper M, et al.: Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemical. Carcinogenesis 25, 847–855, 2004.
  • Donnelly ET, Bardwell H, Thomas GA, Williams ED, Hoper M, et al.: Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. Br J Cancer 92, 2160–2165, 2005.
  • Bruewer M, Schmid KW, Krieglstein CF, Senninger N, and Schuermann G: Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma. World J Surg 26, 726–731, 2002.
  • Hishikawa Y, Kohno H, Ueda S, Kimoto T, Dhar DK, et al.: Expression of metallothionein in colorectal cancers and synchronous liver metastases. Oncology 61, 162–167, 2001.
  • Boman BM, Walters R, Fields JZ, Kovatich AJ, Zhang T, et al.: Colonic Crypt changes during adenoma development in familial adenomatous polyposis. immunohistochemical evidence for expansion of the crypt base cell population. Am J Pathol 165, 1489–1498, 2004.
  • Reeves PG, Nielsen FH, and Fahey GC Jr.: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939–1951, 1993.
  • Triolet J, Shaik AA, Gallaher DD, O'Sullivan MG, and Xing C: Reduction in colon cancer risk by consumption of kava or kava fractions in carcinogen-treated rats. Nutr Cancer 64, 838–846, 2012.
  • Bird RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37, 147–151, 1987.
  • Roncucci L, Medline A, and Bruce WR: Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev 1, 57–60, 1991.
  • Di Gregorio C, Losi L, Fante R, Modica S, Ghidoni M, et al.: Histology of aberrant crypt foci in the human colon. Histopathology 30, 328–334, 1997.
  • Lambert R, Kudo SE, Vieth M, Allen JI, Fujii H, et al.: Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc 70, 1182–1199, 2009.
  • Ilyas M: Wnt signalling and the mechanistic basis of tumour development. The Journal of Pathology 205, 130–144, 2005.
  • Hao XP, Pretlow TG, Rao JS, and Pretlow TP: Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 61, 8085–8088, 2001.
  • MacDonald BT, Tamai K, and He X: Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell 17, 9–26, 2009.
  • Park S and Choi J: Inhibition of beta-catenin/Tcf signaling by flavonoids. J Cell Biochem 110, 1376–1385, 2010.
  • Wang LS, Kuo CT, Cho SJ, Seguin C, Siddiqui J, et al.: Black raspberry-derived anthocyanins demethylate tumor suppressor genes through the inhibition of DNMT1 and DNMT3B in colon cancer cells. Nutr Cancer 65, 118–125, 2013.
  • Abdel-Aal ESM, Young JC, and Rabalski I: Anthocyanin composition in black, blue, pink, purple, and red cereal grains. J Agric Food Chem 54, 4696–4704, 2006.
  • Williams ED, Lowes AP, Williams D, and Williams GT: A stem cell niche theory of intestinal crypt maintenance based on a study of somatic mutation in colonic mucosa. Am J Pathol 141, 773–776, 1992.
  • Giacomini CP, Leung SY, Chen X, Yuen ST, Kim YH, et al.: A gene expression signature of genetic instability in colon cancer. Cancer Res 65, 9200–9205, 2005.
  • Mori F, Della Rocca C, and Lazzaro D: Metallothionein colon crypt immuno-positivity as a rapid in vivo essay for drug efficacy studies. In Vivo 26, 693–702, 2012.
  • Rao CV, Simi B and Reddy BS: Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14, 2219–2225, 1993.
  • Rao CV, Rivenson A, Simi B, and Reddy BS: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55, 259–266, 1995.
  • Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, et al.: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12, 468–476, 2010.
  • Parnaud G, Tache S, Peiffer G, and Corpet DE: Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res 59, 5143–5147, 1999.
  • Morishita Y, Yoshimi N, Kawabata K, Matsunaga K, Sugie S, et al.: Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon. Cancer Sci 88, 815–820, 1997.
  • Tao L, Li K, and Pereira MA: Chemopreventive agents-induced regression of azoxymethane-induced aberrant crypt foci with the recovery of hexosaminidase activity. Carcinogenesis 18, 1415–1418, 1997.
  • Sosulski FW, Krygier K, and Hogge L: Free, Esterified, and insoluble-bound phenolic acids: 3. Composition of phenolic acids in cereal and potato flours. J Agri Food Chem 30, 337–340, 1982.
  • Femia AP, Paulsen JE, Dolara P, Alexander J, and Caderni G: Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis. Anticancer Res 28, 3771–3775, 2008.
  • Femia AP, Bendinelli B, Giannini A, Salvadori M, Pinzani P, et al.: Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats. Int J Cancer 116, 9–15, 2005.
  • Maziya-Dixon BB, Klopfenstein CF, and Leipold HW: Protective effects of hard red versus hard white winter wheats in chemically induced colon cancer in CF1 mice. Cereal Chem 71, 359–363, 1994.
  • Adom KK, Sorrells ME, and Liu RH: Phytochemical profiles and antioxidant activity of wheat varieties. J Agric Food Chem 51, 7825–7834, 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.